Dexamethasone

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37

Among ALL survivors who were younger than 15 years at diagnosis, each additional 1000 mg/m2 of dexamethasone exposure increased the odds of drug-induced diabetes during treatment by 58%.

Effect: decline; OR 1.58 per 1000 mg/m2; CI: 95% CI 1.05-2.37